Locations:
Search
First-in-human phase 1 trial induced loss of function in gene that codes for ANGPTL3
Blood test can identify patients who need more frequent monitoring or earlier surgery to prevent dissection or rupture
Phase 3 TANDEM study may help pave way to first approval of a CETP inhibitor
5% of flagged ECGs in real-world study were from patients with previously undiagnosed HCM
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Metabolites from animal product substrates implicated in heart failure development in community cohorts
Study authors urge reevaluation of the sweetener’s safety designation by food regulators
Surprise findings argue for caution about testosterone use in men at risk for fracture
Findings support emphasis on markers of frailty related to, but not dependent on, age
One-time infusion of adenovirus-based therapy is designed to restore heart muscle function
Additional analyses of the two trials presented at 2023 ESC Congress
Advertisement
Advertisement